• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.83 Down 0.03(3.49%) Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:0.86
    Open:0.86
    Bid:0.83 x 1100
    Ask:0.85 x 2300
    1y Target Est:5.00
    Beta:2.09
    Next Earnings Date:N/A
    Day's Range:0.83 - 0.86
    52wk Range:0.70 - 2.20
    Volume:73,542
    Avg Vol (3m):129,773
    Market Cap:23.39M
    P/E (ttm):N/A
    EPS (ttm):-0.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXADown 3.49%23.39M
    SNYDown 0.90%121.74B
    TEVAUp 2.38%49.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.58
    Quarterly EPS Est (Dec-14) :-0.15
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback